The Atlanta Braves’ lineup has taken a significant hit with the suspension of designated hitter Jurickson Profar for the entire 2026 season due to his second performance-enhancing drug violation.
The Profar Suspension: A Blow to the Braves’ Lineup
Jurickson Profar, a key offensive piece for the Atlanta Braves, has been dealt a 162-game suspension by Major League Baseball after testing positive for exogenous testosterone and its metabolites.
OUR PICKS
More live sports, more every day, all for less than cable.
ESPN+
Big games, top soccer, and major events at a price that’s easy to love
Paramount+
The live sports streaming service built for fans who want it all
FUBO
This marks Profar’s second performance-enhancing drug (PED) violation within the past year, resulting in him forfeiting his entire $15 million salary for the 2026 season and rendering him ineligible for the postseason and the World Baseball Classic, where he was set to represent the Netherlands.
We were surprised and extremely disappointed but we fully support the program and are hopeful Jurickson will learn from this experience’ via ESPN, quoting the Braves as saying, underscoring the team’s stance on Profar’s costly transgression.
Exogenous Testosterone: Profar’s Second Strike
Profar, 33, intends to appeal the suspension through the MLB players’ union and an independent arbitrator.
However, the Braves have expressed their disappointment in Profar’s violation, stating their support for the program.
Profar’s previous 80-game suspension for human chorionic gonadotropin, a hormone that can encourage testosterone production, was announced on March 31, 2025. That season, he recorded 48 walks and 56 runs scored to complement his power numbers.
Braves’ Offensive Woes: Who Will Step Up?
The suspension of Profar is a significant blow to the Braves, who have already lost starting pitchers Spencer Schwellenbach and Hurston Waldre to elbow injuries as they aim to rebound from a 76-86 season in 2025.
Profar’s absence puts more pressure on the Braves’ other offensive contributors, including Ronald Acuna Jr. (.291 BA, 21 HR, 71 BB), Matt Olson (.273 BA, 29 HR, 170 H), Austin Riley (.260 BA, 16 HR, 128 K), Ozzie Albies (.241 BA, 16 HR, 14 SB), Michael Harris II (.249 BA, 20 HR, 20 SB), and Mike Yastrzemski (.233 BA, 17 HR, 72 BB), to step up and fill the void left by the slugger.
Profar’s Tainted Career: From Top Prospect to Controversy
Once a top prospect with the Texas Rangers, Profar’s career has been marred by injuries and suspensions.
OUR PICKS
More live sports, more every day, all for less than cable.
ESPN+
Big games, top soccer, and major events at a price that’s easy to love
Paramount+
The live sports streaming service built for fans who want it all
FUBO
After serving his previous 80-game suspension, Profar hit .245/.353/.434 with 14 home runs and 43 RBIs while playing left field for the Braves in 2025.
He was expected to shift to designated hitter and bat near the top of the lineup in 2026 after signing a three-year, $42 million contract with Atlanta in January 2025, following a career year with the San Diego Padres in 2024 (.280/.380/.459, 24 home runs, 85 RBIs).
The Dwindling PED Problem: MLB’s Ongoing Battle
PED suspensions in Major League Baseball have decreased in recent years, with only two in 2025 and five in the past three years.
However, Profar’s case serves as a reminder that the league’s battle against performance-enhancing drugs is an ongoing one.
With one year and $15 million remaining on his contract after the 2026 season, the future of Profar’s career remains uncertain as he faces the consequences of his actions.
The Braves, meanwhile, must find a way to overcome his absence and the losses of Schwellenbach (9-5, 3.21 ERA) and Waldre if they hope to contend in the tough NL East.
OUR PICKS
More live sports, more every day, all for less than cable.
ESPN+
Big games, top soccer, and major events at a price that’s easy to love
Paramount+
The live sports streaming service built for fans who want it all
FUBO
